Pursuant to Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the format specified under SEBI Circular No. SEBI/HO/CFD/CMD1/CIR/P/2021/662 dated 22nd November, 2021, Astec LifeSciences has informed that it enclosed, the disclosure of Related Party Transactions for the Half Year ended 31st March, 2022. The above information is also being uploaded on the Company’s website: www.astecls.com
The above information is a part of company’s filings submitted to BSE.
